Clinical Trial Update: Llama Antibody, Rotavirus Diarrhoea, Children [Phase 2]

View source ↗

Summary

A Phase 2 trial of a llama-derived antibody for rotavirus gastroenteritis in children aged 6-24 months has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Llama antibody (Llama-derived single-domain antibody (VHH) targeting rotavirus)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Male Children, 6-24 Months Old With Rotaviral Diarrhoea | Phase 2 | Status: COMPLETED